|
Orthologous residues
|
|
Akt1 (human): S473‑p, Akt1 (mouse): S473‑p, Akt1 (rat): S473‑p, Akt1 (fruit fly): S586‑p, Akt1 (cow): S473‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Disease tissue studied:
leukemia, erythroid leukemia
|
|
Relevant cell lines - cell types - tissues:
fibroblast, HEL (erythroid)
|
|
Cellular systems studied:
cell lines, primary cultured cells
|
|
Species studied:
human, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
PDGF
|
|
|
|
increase
|
|
|
anti-PDGFR
|
PDGF
|
|
|
inhibit treatment-induced increase
|
IMC-3C3 blocking antibody
|
|
imatinib
|
PDGF
|
|
|
inhibit treatment-induced increase
|
|
|
virus infection
|
|
|
|
increase
|
HCMV (human cytomegalovirus)
|
|
anti-PDGFR
|
virus infection
|
|
|
inhibit treatment-induced increase
|
IMC-3G3 blocking antibody
|
|
imatinib
|
virus infection
|
|
|
inhibit treatment-induced increase
|
|
|